C. Neil Lyons
Direttore/Membro del Consiglio presso Panacela Labs, Inc.
Profilo
C.
Neil Lyons is currently the Director at Panacela Labs, Inc. He previously worked as the CFO, Treasurer, CAO & Head-Investor Relations at RegeneRx Biopharmaceuticals, Inc. from 2005 to 2011.
He also worked as the Chief Financial Officer at HFS, Inc. and Vice President-Finance at SkyBridge LP.
From 1996 to 1998, he was a Senior Financial Executive at Bell Atlantic Corp.
He received his undergraduate degree from Florida Southern College.
Posizioni attive di C. Neil Lyons
| Società | Posizione | Inizio |
|---|---|---|
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Direttore/Membro del Consiglio | 01/04/2014 |
Precedenti posizioni note di C. Neil Lyons
| Società | Posizione | Fine |
|---|---|---|
| STATERA BIOPHARMA, INC. | Direttore Finanziario/CFO | 06/05/2016 |
| REGENERX BIOPHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 31/08/2011 |
| HFS, Inc. | Direttore Finanziario/CFO | 20/04/2005 |
| SkyBridge LP | Direttore Finanziario/CFO | 01/01/2003 |
| Bell Atlantic Corp. | Corporate Officer/Principal | 01/01/1998 |
Formazione di C. Neil Lyons
| Florida Southern College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
| HFS, Inc. | Commercial Services |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |
| Bell Atlantic Corp. | Communications |
| SkyBridge LP |
- Borsa valori
- Insiders
- C. Neil Lyons
